Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin
Mark Kidd(Wren Laboratories (United States)), John R. Murren(Comprehensive Cancer Centers of Nevada)
Cited by 50
Related Papers
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
|European Journal of Nuclear Medicine and Molecular Imaging|2014|465
A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases
|Epigenetics & Chromatin|2014|70